Bio Financial Statements From 2010 to 2024

BIO-B Stock  USD 325.85  0.00  0.00%   
Bio Rad financial statements provide useful quarterly and yearly information to potential Bio Rad Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bio Rad financial statements helps investors assess Bio Rad's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bio Rad's valuation are summarized below:
Gross Profit
1.6 B
Profit Margin
(0.30)
Market Capitalization
9.2 B
Enterprise Value Revenue
3.4894
Revenue
2.6 B
We have found one hundred twenty available fundamental signals for Bio Rad Laboratories, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Bio Rad Laboratories prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 919.2 M. The current year's Enterprise Value is expected to grow to about 1 B

Bio Rad Total Revenue

1.38 Billion

Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 153.2 M, Interest Expense of 51.9 M or Selling General Administrative of 475.9 M, as well as many indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Bio Rad Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12.9 B12.3 B7.2 B
Slightly volatile
Short and Long Term Debt Total1.5 B1.4 B576.9 M
Slightly volatile
Other Current Liabilities317.1 M302 M244.8 M
Slightly volatile
Total Current Liabilities338.4 M522.8 M492.7 M
Slightly volatile
Total Stockholder Equity9.2 B8.7 B5.1 B
Slightly volatile
Property Plant And Equipment Net759.9 M723.7 M521.4 M
Slightly volatile
Retained Earnings9.7 B9.3 B4.8 B
Slightly volatile
Cash257.1 M404 M427.1 M
Pretty Stable
Non Current Assets Total9.7 B9.3 B5.2 B
Slightly volatile
Cash And Short Term Investments1.7 B1.6 B958.4 M
Slightly volatile
Net Receivables272.4 M489 M382.3 M
Slightly volatile
Common Stock Shares Outstanding29.1 M29.2 M28.9 M
Slightly volatile
Liabilities And Stockholders Equity12.9 B12.3 B7.2 B
Slightly volatile
Non Current Liabilities Total3.2 BB1.6 B
Slightly volatile
Inventory819.5 M780.5 M542.5 M
Slightly volatile
Other Current Assets92.3 M171.7 M134.2 M
Very volatile
Total Liabilities3.7 B3.6 B2.1 B
Slightly volatile
Total Current Assets3.2 BBB
Slightly volatile
Short Term Debt33.9 M40.4 M41.8 M
Pretty Stable
Accounts Payable116.6 M144.6 M177.8 M
Pretty Stable
Intangible Assets188.7 M320.5 M212.2 M
Slightly volatile
Common Stock2.6 K2.7 K836.1 K
Slightly volatile
Current Deferred Revenue37.5 B35.8 B4.9 B
Slightly volatile
Common Stock Total Equity3.3 K3.5 K136.2 K
Pretty Stable
Property Plant And Equipment Gross1.7 B1.8 B92.9 B
Pretty Stable
Short Term Investments1.3 B1.2 B531.2 M
Slightly volatile
Good Will419.6 M413.6 M396.3 M
Very volatile
Net Tangible Assets5.4 B10.6 BB
Slightly volatile
Noncontrolling Interest In Consolidated Entity428 K481.5 K524.3 K
Slightly volatile
Long Term Debt1.3 B1.2 B565.2 M
Pretty Stable
Retained Earnings Total Equity12 B11.4 B5.2 B
Slightly volatile
Long Term Debt Total1.1 B1.1 B550.4 M
Pretty Stable
Capital Surpluse384.1 M514.6 M344.3 M
Slightly volatile
Deferred Long Term Liabilities2.1 BB931.6 M
Slightly volatile
Non Current Liabilities Other216 M195.1 M185.9 M
Slightly volatile
Deferred Long Term Asset Charges12.4 M13.9 M15.2 M
Slightly volatile
Property Plant Equipment538.6 M573.4 M488.8 M
Slightly volatile
Long Term Investments5.1 B7.7 B3.8 B
Slightly volatile
Other Liabilities1.3 B2.3 BB
Slightly volatile
Short and Long Term Debt461.7 K486 K203 M
Slightly volatile
Net Invested CapitalB9.9 BB
Slightly volatile
Net Working Capital1.9 B2.5 B1.6 B
Slightly volatile
Capital Stock2.4 K2.7 K2.9 K
Slightly volatile
Capital Lease Obligations165 M205.9 M206.6 M
Slightly volatile

Bio Rad Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization153.2 M145.9 M100.7 M
Slightly volatile
Interest Expense51.9 M49.4 M30.9 M
Very volatile
Selling General Administrative475.9 M846.8 M727.3 M
Slightly volatile
Total Revenue1.4 B2.7 B2.1 B
Slightly volatile
Gross Profit769.3 M1.4 B1.2 B
Slightly volatile
Other Operating Expenses1.2 B2.3 B1.9 B
Slightly volatile
Cost Of Revenue1.3 B1.2 B992.5 M
Slightly volatile
Total Operating Expenses614.9 M1.1 B928.6 M
Slightly volatile
Research Development161.8 M226.9 M203.8 M
Slightly volatile
Non Operating Income Net Other54.1 M51.5 M21.8 M
Slightly volatile
Minority Interest36 K18.9 K31.5 K
Slightly volatile
Non Recurring353.2 M336.4 M173.3 M
Slightly volatile
Interest Income101.2 M96.4 M31.5 M
Slightly volatile
Reconciled Depreciation111.4 M144.2 M141.8 M
Slightly volatile
Selling And Marketing Expenses1.2 M1.3 M1.5 M
Slightly volatile

Bio Rad Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow271.2 M434.5 M462.2 M
Very volatile
Depreciation202 M192.4 M137 M
Slightly volatile
Capital Expenditures84.5 M156.7 M113 M
Pretty Stable
Total Cash From Operating Activities393.7 M374.9 M296.1 M
Slightly volatile
End Period Cash Flow286.4 M404.4 M429.6 M
Pretty Stable
Change Receivables82.3 M78.4 M30.8 M
Slightly volatile
Dividends Paid105.1 B100.1 B21.1 B
Slightly volatile
Cash Flows Other Operating137.9 M145.2 M264.1 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.713.53073.2598
Slightly volatile
PTB Ratio2.151.0791.8203
Slightly volatile
Days Sales Outstanding87.3166.819168.6533
Pretty Stable
Book Value Per Share314299174
Slightly volatile
Operating Cash Flow Per Share13.4812.836610.0993
Slightly volatile
Stock Based Compensation To Revenue0.02410.02290.0125
Slightly volatile
Capex To Depreciation1.40.960.9684
Pretty Stable
PB Ratio2.151.0791.8203
Slightly volatile
EV To Sales4.13.90563.3257
Slightly volatile
Inventory Turnover2.191.58861.9156
Pretty Stable
Days Of Inventory On Hand149230191
Pretty Stable
Payables Turnover5.698.57337.6168
Slightly volatile
Sales General And Administrative To Revenue0.430.420.3787
Pretty Stable
Research And Ddevelopement To Revenue0.10.0850.0949
Pretty Stable
Capex To Revenue0.06970.05870.0549
Pretty Stable
Cash Per Share57.7855.027332.7138
Slightly volatile
POCF Ratio15.1825.153926.5811
Slightly volatile
Capex To Operating Cash Flow0.40.41790.5511
Slightly volatile
Days Payables Outstanding58.9242.57448.8113
Slightly volatile
EV To Operating Cash Flow17.427.82527.5784
Slightly volatile
Intangibles To Total Assets0.05670.05970.1242
Slightly volatile
Current Ratio6.125.83084.0248
Slightly volatile
Tangible Book Value Per Share288274153
Slightly volatile
Receivables Turnover3.785.46255.3723
Pretty Stable
Graham Number402383345
Slightly volatile
Shareholders Equity Per Share314299174
Slightly volatile
Debt To Equity0.130.13610.2055
Slightly volatile
Capex Per Share5.635.36414.0572
Slightly volatile
Revenue Per Share96.0391.453475.581
Slightly volatile
Interest Debt Per Share44.5442.414719.8115
Slightly volatile
Debt To Assets0.09190.09670.12
Slightly volatile
Short Term Coverage Ratios395376446
Pretty Stable
Operating Cycle292297264
Slightly volatile
Price Book Value Ratio2.151.0791.8203
Slightly volatile
Days Of Payables Outstanding58.9242.57448.8113
Slightly volatile
Price To Operating Cash Flows Ratio15.1825.153926.5811
Slightly volatile
Company Equity Multiplier2.191.4071.5858
Slightly volatile
Long Term Debt To Capitalization0.110.11980.1406
Slightly volatile
Total Debt To Capitalization0.110.11980.1521
Slightly volatile
Debt Equity Ratio0.130.13610.2055
Slightly volatile
Quick Ratio4.554.33782.9339
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.742.3932.4405
Slightly volatile
Net Income Per E B T0.580.74970.7564
Very volatile
Cash Ratio0.410.77270.8171
Pretty Stable
Cash Conversion Cycle239254220
Pretty Stable
Operating Cash Flow Sales Ratio0.080.14040.1212
Slightly volatile
Days Of Inventory Outstanding149230191
Pretty Stable
Days Of Sales Outstanding87.3166.819168.6533
Pretty Stable
Cash Flow Coverage Ratios0.30.315219.1023
Pretty Stable
Price To Book Ratio2.151.0791.8203
Slightly volatile
Fixed Asset Turnover5.533.69094.7057
Slightly volatile
Capital Expenditure Coverage Ratio1.742.3932.4405
Slightly volatile
Price Cash Flow Ratio15.1825.153926.5811
Slightly volatile
Debt Ratio0.09190.09670.12
Slightly volatile
Cash Flow To Debt Ratio0.30.315219.1023
Pretty Stable
Price Sales Ratio3.713.53073.2598
Slightly volatile
Asset Turnover0.210.21720.4842
Slightly volatile
Gross Profit Margin0.630.53580.5575
Pretty Stable
Price Fair Value2.151.0791.8203
Slightly volatile

Bio Rad Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap919.2 M875.4 M906.2 M
Slightly volatile
Enterprise ValueB952.4 M987.1 M
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings28.6533
Cash And Short Term Investments1.6 B

About Bio Rad Financial Statements

Bio Rad stakeholders use historical fundamental indicators, such as Bio Rad's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Rad investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bio Rad's assets and liabilities are reflected in the revenues and expenses on Bio Rad's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bio Rad Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue35.8 B37.5 B
Total Revenue2.7 B1.4 B
Cost Of Revenue1.2 B1.3 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.42  0.43 
Research And Ddevelopement To Revenue 0.08  0.10 
Capex To Revenue 0.06  0.07 
Revenue Per Share 91.45  96.03 
Ebit Per Revenue 0.14  0.08 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.